Gliquidone
CAS No. 33342-05-1
Gliquidone ( Gliquidone; Glurenorm; Beglynor; Glikvidon; Glycvidon )
Catalog No. M14125 CAS No. 33342-05-1
Gliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 31 | In Stock |
|
50MG | 42 | In Stock |
|
100MG | 51 | In Stock |
|
200MG | 75 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGliquidone
-
NoteResearch use only, not for human use.
-
Brief DescriptionGliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2.
-
DescriptionGliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is an ATP-dependent K+ (KATP) channel blocker. This block causes a depolarization which leads to activation of voltage-dependent Ca channels and Ca2+ influx, and eventually increases insulin release.
-
SynonymsGliquidone; Glurenorm; Beglynor; Glikvidon; Glycvidon
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number33342-05-1
-
Formula Weight527.63
-
Molecular FormulaC27H33N3O6S
-
Purity>98%(HPLC)
-
SolubilityEthanol: 6 mg/mL (11.37 mM); DMSO: 105 mg/mL (199.0 mM)
-
SMILESCC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C
-
Chemical Name1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Angel I, et al. Fundam Clin Pharmacol, 1991, 5(2), 107-115.
molnova catalog
related products
-
DCEBIO
DCEBIO stimulates the secretion of Cl- through the activation of the hIK1 K + channel and the activation of the apical Cl- conductance.
-
NS 1619
NS1619 have been reported to have cardio-protective effects after ischemic-reperfusion injury.
-
Rimtuzalcap
Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels).